MHA Monday Report Sept. 26, 2022

MHA Monday Report

Michigan Hospitals Invested $4.2 Billion in Community Programming Mid-pandemic


Legislature Returns to Continue Healthcare-related Work


MHA Hosts Valuable Advocacy Events


MHA Launches Physician Membership with AAPL Partnership

The MHA and the American Association for Physician Leadership (AAPL) announced a partnership Sept. 22 that will provide leadership education and training to MHA physician members. The announcement expands the range of benefits offered through …


Michigan Healthcare Leaders Speak on Clinical Genomics During White House Panel


Webinar Highlights Discipline Required to Accomplish Strategic Goals

Now is the time to maximize board resources to design healthcare that is affordable, equitable and focused on your community’s needs. To effectively create strategies, an organization’s leadership must agree on the approach, terminology and …


Suicide Prevention Focus of AHA Trustee Insights

September is National Suicide Prevention Awareness Month and an opportunity to be reminded of the many resources available to support emotional well-being. The September edition of Trustee Insights, the monthly digital package from the American Hospital …


The Keckley Report

The two changes most likely in the value agenda of the U.S health system

“This week, the celebration of Queen Elizabeth’s life will take center stage leading up to her funeralPaul Keckley September 19. The 96-year old’s longevity, the mystique of the monarchy and Britain’s oversized role in Western culture will be table talk. …

The structure of the UK and US health systems are different. Per the Organisation for Economic Co-operation and Development, the health system in the US is more expensive, more fragmented and less effective in optimizing the population’s health than the [National Health Service] and many other developed systems. Several factors explain the difference: social determinants, violence, unit prices paid for drugs, specialty care and hospitals in the U.S. and others.”

Paul Keckley, Sept. 19, 2022


News to KnowLogo for MI Vote Matters, Tuesday Nov. 8

As Election Day nears, the MHA continues to offer complimentary MI Vote Matters informational posters and the 2022 Candidate Guide for members’ use in encouraging their communities to vote.


MHA in the News
Brian Peters

The MHA received media coverage on several topics during the week of Sept. 12. Areas of focus included the Economic Impact of Healthcare in Michigan report and the new national rural emergency hospital (REH) designation. …

Michigan Healthcare Leaders Speak on Clinical Genomics During White House Panel

MHA EVP Laura Appel joins experts from MDHHS, BCBSM, Michigan Medicine and Beaumont Health

The MHA and fellow healthcare leaders joined a virtual panel discussion on clinical genomics Sept. 22 hosted by the White House Office of Science and Technology Policy and the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

The purpose of the webinar was to raise awareness about the clinical utility and lifesaving potential of clinical genome sequencing, as well as highlight coverage models for state Medicaid programs and private payors to help enable equitable access.

According to the National Department of Health and Human Services (HHS) and the National Institutes of Health, recent technological advances have made it possible for clinicians to quickly sequence the genomes of critically ill newborns and children to rapidly make a diagnosis. This powerful technology can transform lives by identifying potentially lifesaving and life-changing medical treatment. However, despite the enormous promise of genome sequencing to improve health outcomes, not all patients who might benefit from this technology can access it.

Laura Appel, executive vice president of Government Relations & Public Policy at the MHA, joined the conversation to speak on our state’s model for advancing coverage of genomic sequencing. Other panelists from Michigan healthcare institutions, included:

  • Brian Keisling, director of bureau of Medicaid policy at the Michigan Department of Health & Human Services.
  • Caleb Bupp, M.D., FACMG, division chief of medical genetics & genomics at Beaumont Health Spectrum Health and Helen DeVos Children’s Hospital.
  • Lynne Carter, M.D., MPH, medical director at Blue Cross Blue Shield of Michigan.
  • Wendy R. Uhlmann, M.S., LCGC, genetic counselor and clinical professor at the Departments of Internal Medicine (Division of Genetic Medicine) and Human Genetics at the University of Michigan.

During the discussion, the group touched on Project Baby Deer, an initiative that provides rapid whole genome sequencing testing for critically ill infants up to one year of age. The program can enhance clinical management of young patients by initiating life-saving treatments, avoiding unnecessary tests and procedures, shortening hospital stays and helping families with treatment decision-making.

To learn more about clinical genome sequencing, visit the HHS website. Those with questions about Project Baby Deer may contact Laura Appel at the MHA.